General form of registration statement for all companies including face-amount certificate companies

CONSOLIDATED BALANCE SHEETS

v3.10.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2018
Dec. 31, 2017
Dec. 31, 2016
Current assets:      
Cash $ 245,373 $ 11,342 $ 92,455
Accounts receivable, net 15,750 29,950
Prepaid expenses 18,341 13,210 8,400
Total current assets 279,464 54,502 100,855
Property and equipment, net 44,687 19,012 22,164
Other assets:      
Restricted cash   50,000
Intellectual property, net 250,000 251,963 279,729
Deposits, long term 13,422 13,422 17,634
Total other assets 263,422 265,385 347,363
Total assets 587,573 338,899 470,382
Current liabilities:      
Accounts payable and accrued expenses, including related party payables of $37,118 and $62,241, respectively 1,394,315 1,199,536 937,938
Deferred revenue, short term 215,236 237,347 432,836
Settlement payable 15,000 315,000
Convertible notes payable, short term, net of debt discount 3,128,780 87,033
Notes payable, net of debt discount, short term portion 250,000 172,748
Notes payable, net of debt discount, related party 186,590 186,590 210,761
Derivative liability   294,807
Total current liabilities 5,174,921 1,638,473 2,451,123
Long term debt:      
Deferred revenue, long term 245,935 401,346 613,428
Convertible notes payable, long term, net of debt discount 2,016,041 688,783
Warrant liability 175,975 26,903
Derivative liability   4,820,473
Total long term debt 245,935 2,593,362 6,149,587
Total liabilities 5,420,856 4,231,835 8,600,710
Commitments and contingencies (See Note 18)
Stockholders' deficit:      
Preferred stock value 16,000 16,000 16,000
Common stock, $0.001 par value; 750,000,000 shares authorized, 2,532,863 and 2,440,863 shares issued and outstanding as of September 30, 2018 and December 31, 2017, respectively 2,533 2,441 1,818
Common stock subscribed 200,000 100,000 100,000
Additional paid in capital 47,716,973 44,823,541 10,881,103
Accumulated deficit (52,771,032) (48,840,534) (19,134,865)
Total stockholders' deficit attributable to BioCorRx, Inc. (4,829,910) (3,892,936)  
Non-controlling interest (3,373)  
Total deficit (4,833,283) (3,892,936) (8,130,328)
Total liabilities and deficit 587,573 338,899 470,382
Series B Preferred Stock [Member]      
Stockholders' deficit:      
Preferred stock value $ 5,616 $ 5,616 $ 5,616